Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations

Annals of Thoracic Surgery

Volumn 61, Issue 5, 1996, Pages 1323-1329

  Klemperer, John D ^a   Klein, Irwin L ^b   Ojamaa, Kaie ^b   Helm, Robert E ^b   Gomez, Maureen ^b   Isom, O Wayne ^b   Krieger, Karl H ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE;

ADULT; AGED; CONFERENCE PAPER; FEMALE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029962172     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00102-6     Document Type: Conference Paper

References (28)

1. Lauer MS, Eagle KA, Buckley MJ, et al. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989;31:367-78.
2. Cox JL. A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg 1993;56:405-9.
3. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993; 56:539-49.
4. Silverman NA, Wright R, Levitsky S. Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Ann Surg 1982;196:194-7.
5. Matangi MF, Neutze JM, Graham KJ, Hill DG, Kerr AR, Barratt-Boyes BG. Arrhythmia prophylaxis after aortacoronary bypass: the effect of minidose propranolol. J Thorac Cardiovasc Surg 1985;89:439-43.
6. Suttorp MJ, Kingma JH, Peels HO, et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol 1991;68:1163-9.
7. Fanning WJ, Thomas CS, Roach A, Tomichek R, Alford WC, Stoney WS. Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting. Ann Thorac Surg 1991;52:529-33.
8. Ko W, Krieger KH, Lazenby WD, et al. Isolated coronary artery bypass grafting in one hundred consecutive octogenarian patients. J Thorac Cardiovasc Surg 1991;102:532-8.
9. Klein I. Thyroid hormone and the cardiovascular system. Am J Med 1990;88:631-7.
10. Klemperer JD, Ojamaa K, Klein I. Thyroid hormone therapy in cardiovascular disease. Prog Cardiovasc Dis 1996;38: 329-37.
11. Salter DR, Dyke CM, Wechsler AS. Triiodothyronine (T3) and cardiovascular therapeutics: a review. J Cardiac Surg 1992;7:363-74.
12. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary artery bypass surgery. N Engl J Med 1995;333:1522-7.
13. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331:1249-52.
14. Sato S, Yamaguchi S, Schuessler RB, Boineau JP, Matsunaga Y, Cox JL. The effect of augmented atrial hypothermia on atrial refractory period, conduction, and atrial flutter/fibrillation in the canine heart. J Thorac Cardiovasc Surg 1992;104:297-306.
15. Mullen JC, Khan N, Weisel RD, et al. Atrial activity during cardioplegia and postoperative arrhythmias. J Thorac Cardiovasc Surg 1987;94:558-65.
16. Tchervenkov CI, Wynands JE, Symes JF, Malcolm ID, Dobell ARC, Morin JE. Persistent atrial activity during cardioplegic arrest: a possible factor in the etiology of postoperative supraventricular tachyarrhythmias. Ann Thorac Surg 1983; 36:437-43.
17. Leitch JW, Thomson D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1990;100:338-42.
18. Rubin DA, Nieminski KE, Reed GE, Herman MV. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1987;94:331-5.
19. Dyke CM, Yeh T Jr, Lehman JD, et al. Triiodothyronine-enhanced left ventricular function after ischemic injury. Ann Thorac Surg 1991;52:14-9.
20. Holland FW, Brown PS Jr, Clark RE. Acute severe postischemic myocardial depression reversed by triiodothyronine. Ann Thorac Surg 1992;54:301-5.
21. Klemperer JD, Zelano J, Helm R, et al. Triiodothyronine improves left ventricular function without oxygen wasting effects following global hypothermic ischemia. J Thorac Cardiovasc Surg 1995;109:457-65.
22. Dyke CM, Ding M, Abd-Elfattah AS, et al. Effects of triiodothyronine supplementation after myocardial ischemia. Ann Thorac Surg 1993;56:215-22.
23. Coumel P. Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur Heart J 1994;15(Suppl A):9-16.
24. Ali IM, Butler CK, Armour A, Murphy DA. Modification of supraventricular tachyarrhythmias by stimulating atrial neurons. Ann Thorac Surg 1990;50:251-6.
25. Safran M, Farwell AP, Leonard JL. Thyroid hormone-dependent redistribution of the 55-kilodalton monomer of protein disulfide isomerase in cultured glial cells. Endocrinology 1992;131:2413-8.
26. D'Alecy L. Thyroid hormone in neural rescue. Proceedings of the Novel Actions of Thyroid Hormone Satellite Meeting of the International Thyroid Congress, Toronto, Canada, 1995:abstract 7.
27. Dudley SC, Baumgarten CM. Bursting of cardiac sodium channels after acute exposure to 3,5,3′ triiodo-L-thyronine. Circ Res 1993;73:301-13.
28. Kupfer LE, Bilzekian JP, Robinson RB. Regulation of alpha and beta adrenergic receptors by triiodothyronine in cultured rat myocardial cells. Naunyn Schmiedebergs Arch Pharmacol 1986;334:275-81.